Armata Pharmaceuticals Inc. (TG1N)
FSX
Real-time Data
06:00 AM
Day's Range
4.3852 wk Range
1.97Overview - TG1N - Armata Pharmaceuticals Inc.
Key Statistics
Valuation
Enterprise Value
367.42M
P/E (Trailing)
‪-0.90‬
P/E (Forward)
‪-4.06‬
PEG Ratio
‪-0.00054‬
Price / Sales (TTM)
‪25.08‬
Price / Book
‪-0.50‬
EV / EBITDA
‪-12.82‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-410.83%‬
Return on Assets
‪-25.83%‬
Return on Equity
‪79.50%‬
Ownership
Shares Outstanding
36.64M
Float
11.90M
Held by Insiders
‪67.63%‬
Held by Institutions
‪13.45%‬
Price stats
Beta
‪1.32‬
50-Day Avg
‪4.61‬
200-Day Avg
‪6.48‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - TG1N - Armata Pharmaceuticals Inc.
Peers - TG1N - Armata Pharmaceuticals Inc.
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- TG1NFSXArmata Pharmaceuticals Inc.160.62MMarket Cap+50.46%52-week change-0.90P/E (Trailing)‪0.00%‬Profit Margin
- ANLFSXAnalog Devices, Inc.152.94BMarket Cap+29.62%52-week change44.47P/E (Trailing)‪29.78%‬Profit Margin
- 1AEFSXargenx SE56.27BMarket Cap+30.57%52-week change39.07P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt54.72BMarket Cap+33.14%52-week change39.13P/E (Trailing)‪32.26%‬Profit Margin
- 0QFFSXModerna, Inc.50.02BMarket Cap+81.89%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 42ZFSXRevolution Medicines Inc.37.93BMarket Cap+83.17%52-week change-30.35P/E (Trailing)‪0.00%‬Profit Margin
- 49BAFSXBeOne Medicines, Ltd. American Depositary Receipt35.29BMarket Cap+16.03%52-week change65.41P/E (Trailing)‪10.69%‬Profit Margin
Profile Summary - TG1N - Armata Pharmaceuticals Inc.
About
Armata Pharmaceuticals Inc. is a biotechnology company dedicated to the development of innovative therapies to treat antibiotic-resistant infections. Operating in the healthcare sector, the company focuses on bacteriophage-based solutions, aiming to address the growing global issue of antimicrobial resistance. Armata…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
